Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Inflammatory demyelinating diseases in children: an update.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
MOG-IgG in neuromyelitis optica.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Improving the quality of mental health care in Multiple Sclerosis.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Free radicals: properties, sources, targets, and their implication in various diseases.
Induction and molecular signature of pathogenic T(H)17 cells.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Atypical Optic Neuritis.
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Mode of action and clinical studies with alemtuzumab.

Pages